Fungi containing psilocybin – otherwise known as magic mushrooms – will be part of government-funded trials into mental health treatments.
By Rob Harris
Clinical trials using magic mushrooms, ecstasy and other psychedelic drugs in potential breakthrough therapies for debilitating mental illnesses will be funded by the federal government as part of global efforts to advance innovative treatments.
There is growing international evidence showing substances such as ketamine, psilocybin and MDMA can successfully treat resistant mental illnesses, including depression and post-traumatic stress disorder, when used in a controlled environment and supported by psychiatric care.
Many standard treatments for illnesses, including addiction and eating disorders, can have varied efficacy and recovery rates and there have been few advances in novel pharmaceutical discoveries in recent years.
The Morrison government will on Wednesday launch a $15 million competitive grant round to kick-start Australian clinical trials of potential breakthrough combination therapies.Continue reading… “‘Better treatments’: Government to fund psychedelic drugs trials to treat mental illness”